IRVINE, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – TRIMEDYNE, INC. (OTCPINK “TMED”) today reported its financial results for its quarter ending on December 31, 2018.
For the Quarter Ended December 31, 2018, Trimedyne had revenues of $1,188,000, a decrease of 23% from revenues of $1,534,000 for the prior year quarter. As a result of this decrease, we had a net loss for the current quarter of $31,000 or $0.25 per share, as compared to net income of $86,000 or $0.70 per share for the prior year quarter.
Commenting on the financial results for the quarter, Marvin P. Loeb, Sc.D., Chairman of Trimedyne, said: “Since we are no longer required to file periodic reports with the SEC, our Financial Statements are un-audited. However, we believe our Financial Statements have been prepared and contain all adjustments of a recurring nature that are necessary for a fair presentation of our operations and financial condition for the period and dates shown in the financial statements attached herein.
“We appreciate the patience of our shareholders, and we are working hard to improve our financial condition.”
To view Trimedyne’s financials, please click on this Link: Trimedyne, Inc.'s Financials for The Quarter Ending on December 31, 2018